Corneal Pachymetry Market

Corneal Pachymetry Market Size

Corneal Pachymetry Market size was valued at around USD 420.5 million in 2023 and is expected to reach around USD 680.3 million by 2032 at a CAGR of 5.8% between 2024 and 2032. The projected rise in the prevalence of eye disorders such as glaucoma and diabetic retinopathy is anticipated to be a key driver for the market.

The rising incidence of eye disorders, notably glaucoma, poses a substantial global health challenge, impacting both public health and healthcare systems. Factors such as aging population, ethnicity, lifestyle choices, chronic diseases, and genetic predispositions contribute significantly to the increase in glaucoma cases. Diabetic retinopathy and glaucoma stand as the primary contributors for blindness and vision impairment globally.

According to the data reported by Centers for Disease Control and Prevention (CDC), diabetic retinopathy ranks as the foremost cause of severe vision loss and blindness among working-age Americans. In 2021, an estimated 4.1 million Americans affected with retinopathy, with 899,000 facing vision-threatening stages of the condition.

Furthermore, glaucoma stands as a leading cause of irreversible blindness in the U.S. As of 2023, over 3 million Americans were affected by glaucoma with limited treatment and cure available for the disorders. Considering these statistics, the increasing prevalence of such conditions underscores the imperative for early detection of these conditions, driving an increased demand for corneal pachymetry devices.

Corneal pachymetry is a medical procedure used to measure the thickness of the cornea, which is the transparent outermost layer of the eye. This measurement is typically performed using specialized instruments called pachymeters, which utilize either ultrasound or optical principles to determine corneal thickness accurately.

Corneal Pachymetry Market Trends

Corneal imaging advancement, cornea diagnosis automation, and advanced technology integration are some of the trending innovations in the corneal pachymetry arena, which are anticipated to propel the market development.

• The advancement of more objective diagnostic tools and improved disease monitoring capabilities represents a significant stride forward, offering invaluable guidance for treatment decisions. For instance, the adoption of in vivo confocal microscopy for corneal sub basal nerve imaging predicts systemic outcomes. This cutting-edge technology enables detailed visualization of corneal structures and pathologies, enabling clinicians with a more accurate and comprehensive understanding of corneal health. Such advancements facilitate enhanced diagnosis and the development of more targeted treatment strategies.
  
• Moreover, the integration of advanced technologies into anterior segment OCT scans, axial refraction, elevation and pachymetry maps, alongside state-of-the-art metrics like the keratoconus ABCD score, has significantly enhanced the diagnostic efficacy of corneal pachymetry devices. This advancement enables more accurate and comprehensive assessments.
  

Corneal Pachymetry Market Analysis

Learn more about the key segments shaping this market

Download Free PDF

Based on product type, the market is segmented into handheld and desktop. The handheld segment is anticipated to reach USD 431 million by 2032.

• Handheld devices offer portability and ease of use, allowing healthcare providers to perform corneal thickness measurements conveniently at various points of care, including outpatient clinics, primary care offices, and remote locations. This portability is particularly advantageous for practitioners who require mobility during patient examinations.  
  
• Moreover, handheld corneal pachymeters may be more cost-effective than their desktop counterparts, making them a preferred choice for healthcare providers operating within constrained budgets, such as small clinics or rural healthcare facilities. The lower initial investment and maintenance costs associated with handheld devices contribute to their increasing adoption.  
  

Based on technology, the corneal pachymetry market is segmented into ultrasonic pachymetry, optical pachymetry and scheimpflug imaging pachymetry. The ultrasonic pachymetry segment held leading revenue of USD 227.1 million in 2023 and is anticipated to witness with a healthy growth rate over the forecast period.

• Ultrasonic pachymetry has been widely regarded as the gold standard for corneal thickness measurements due to its high accuracy and reliability. It provides precise measurements of corneal thickness, making it invaluable for various ophthalmic applications, including preoperative assessment for refractive eye surgery and glaucoma treatment.
  
• Moreover, ultrasonic pachymetry devices are widely and easily available with range of options offered by multiple manufacturers. They come in different configurations and price ranges, making them accessible to healthcare providers with diverse budgetary constraints.
  

Based on application, the corneal pachymetry market is segmented into glaucoma diagnosis, refractive surgery, keratoconus treatment monitoring and other applications. The glaucoma diagnosis segment was valued around USD 180.6 million in 2023.

• Elevated intraocular pressure (IOP) is a key risk factor for glaucoma. Corneal pachymetry helps in accurately measuring central corneal thickness, which in turn allows for more accurate diagnosis and interpretation of IOP measurements. Hence, the above factors may contribute significantly to the segment growth.
  
• Moreover, growing awareness about the importance of regular eye examinations and screening for glaucoma has led to an increase in the number of individuals seeking diagnostic services. Healthcare organizations and advocacy groups often organize screening programs to detect glaucoma in its early stages, further driving demand for glaucoma diagnosis tests.
  

Learn more about the key segments shaping this market

Download Free PDF

The corneal pachymetry market by end-use is categorized into hospitals, specialty clinics, and other end-users. The hospital segment dominates the market with the revenue of around USD 189.9 million in 2023.

• Hospitals, serving as primary healthcare facilities for a significant portion of the population, regularly cater to a diverse patient demographic, including those with intricate eye conditions necessitating specialized care. Given the substantial patient influx in hospitals, there's a vital need for advanced corneal pachymetry devices to meet the growing demand for diagnostic services.
  
• Furthermore, hospitals play a pivotal role as centers for medical research and innovation, particularly in the realm of ophthalmic diagnostics and treatments. They offer the essential infrastructure and resources crucial for supporting research endeavors, thus positioning them as major end users of such advanced diagnostic devices.
  

Looking for region specific data?

Download Free PDF

North America corneal pachymetry market accounted for USD 234.3 million revenue in 2023 and is anticipated to record substantial market growth.

• The region is experiencing a rise in the prevalence of eye disorders such as, keratoconus, and refractive errors. Corneal pachymetry plays a crucial role in the diagnosis and management of these conditions, thereby driving the demand for corneal pachymetry devices.  
  
• Furthermore, there is a growing emphasis on preventive healthcare in North America, including regular eye examinations as part of preventive care routines. This increased focus on preventive care solutions may contribute to the growing demand for this diagnostic procedures.
  

Corneal Pachymetry Market Share

The market is highly competitive, with several major multinational firms competing for dominance alongside small and medium-sized businesses. A crucial aspect of market strategy is the ongoing development and launch of novel products that utilize the diverse technological advances.

Corneal Pachymetry Market Companies

Some of the eminent market participants operating in the corneal pachymetry industry include:

• Carl Zeiss Meditech AG
• DGH Technology, Inc
• Kxele.com
• Lumibird
• NIDEK CO., LTD.
• Reichert Inc.
• Sonomed Escalon
• TOMEY CORPORATION
• Topcon Corporation
• Visionix
  

Corneal Pachymetry Industry News:

• In January 2024, Carl Zeiss Meditec AG entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center (International) B.V. (D.O.R.C.). This acquisition is expected to enhance and complement ZEISS Medical Technology's ophthalmic portfolio, strengthening ZEISS's position in the ophthalmic medical devices market.
  
• In April 2023, NIDEK launched the NT-1/1e non-contact tonometer, which is designed to provide non-contact tonometry for measuring intraocular pressure. This launch improved the company’s product portfolio and improved its reputation in the market.
  

Corneal pachymetry market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 to 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Handheld
• Desktop

By Technology

• Ultrasonic pachymetry
• Optical pachymetry
• Scheimpflug imaging pachymetry

Market, By Application

• Glaucoma diagnosis
• Refractive surgery
• Keratoconus treatment monitoring
• Other applications

By End-use

• Hospitals
• Specialty clinics
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa